Israel China Biotechnology (ICB) Ltd Financial Flexibility Index
Israel China Biotechnology (ICB) Ltd financial flexibility index. Israel China Biotechnology (ICB) Ltd (ICB) has a Financial Flexibility Index of -0.26x as of June 2021. Free cash flow of ILA-1.06 Million (operating CF ILA-1.06 Million minus capex ILA0.00) represents 0% of total liabilities (ILA4.11 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Israel China Biotechnology (ICB) Ltd (2015–2020)
Financial flexibility index of Israel China Biotechnology (ICB) Ltd from 2015 to 2020. Historical Financial Flexibility Index trend for Israel China Biotechnology (ICB) Ltd across 6 annual periods. Check ICB cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Israel China Biotechnology (ICB) Ltd Financial Flexibility Index by Year (2015–2020)
Israel China Biotechnology (ICB) Ltd financial flexibility index by year from 2015 to 2020. Year-by-year free cash flow to debt coverage for Israel China Biotechnology (ICB) Ltd. For the full cash flow conversion analysis, see cash flow conversion of Israel China Biotechnology (ICB) Ltd.
| Year | Flexibility Index | Free Cash Flow (ILA) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2020 | -0.55x | ILA-4.33 Million | ILA-4.34 Million | ILA7.87 Million | ▼ -26.2% |
| 2019 | -0.44x | ILA-4.22 Million | ILA-4.22 Million | ILA9.68 Million | ▲ +75.8% |
| 2018 | -1.80x | ILA-4.43 Million | ILA-4.75 Million | ILA2.46 Million | ▼ -81.1% |
| 2017 | -0.99x | ILA-2.85 Million | ILA-3.17 Million | ILA2.87 Million | ▲ +45.7% |
| 2016 | -1.83x | ILA-3.94 Million | ILA-3.94 Million | ILA2.15 Million | ▼ -16.3% |
| 2015 | -1.58x | ILA-3.77 Million | ILA-3.81 Million | ILA2.39 Million | — |